Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

satavaptan

Known as: Benzamide, N-(1,1-dimethylethyl)-4-((cis-5'-ethoxy-4-(2-(4-morpholinyl)ethoxy)-2'-oxospiro(cyclohexane-1,3'-(3H)indol)-1'(2'H)-yl)sulfonyl)-3-methoxy- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Letter to the Editor: We read with great interest the article by Leithead et al ,1 which showed that non-selective beta-blocker… Expand
Highly Cited
2016
Highly Cited
2016
Proton pump inhibitors (PPIs) may be a risk factor for hepatic encephalopathy (HE) in patients with cirrhosis, possibly through… Expand
Review
2012
Review
2012
Arginine vasopressin (AVP) is a neuropeptide hormone that plays an important role in circulatory and sodium homeostasis, and… Expand
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Highly Cited
2012
Highly Cited
2012
Vaptans may correct hyponatraemia and mobilise ascites through an increased excretion of water. The effect on clinical outcomes… Expand
Highly Cited
2011
Highly Cited
2011
Objective Satavaptan, a vasopressin V2 receptor antagonist, has been shown to improve the control of ascites in cirrhosis in… Expand
Highly Cited
2010
Highly Cited
2010
BACKGROUND & AIMS Cirrhotic patients with recurrent ascites frequently require paracentesis despite diuretic therapy. Vasopressin… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2008
Highly Cited
2008
Hyponatremia in cirrhosis is associated with significant morbidity and mortality and complicates ascites management. Vasopressin… Expand
Review
2008
Review
2008
Arginine-vasopressin is a hormone that plays an important part in circulatory and water homoeostasis. The three arginine… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Review
2007
Review
2007
BackgroundHyponatremia is among the metabolic disturbances encountered in oncology. Risk factors for hyponatremia include… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Highly Cited
2006
Highly Cited
2006
The effects of satavaptan (SR121463B), a novel long-acting orally active vasopressin V(2)-receptor antagonist, were investigated… Expand